معرفی
Dr. Quan Huynh serves as an Adjunct Senior Lecturer at La Trobe University and holds a dual position as Senior Research Officer and Group Leader at the Baker Heart and Diabetes Institute in Melbourne, Australia. His research career spans cardiovascular disease prediction, prevention, and management with particular expertise in heart failure, cognitive impairment interactions, and risk assessment methodologies.
Dr. Huynh's research interests focus on cardiovascular disease prediction and prevention, with special emphasis on heart failure risk stratification, cognitive impairment interactions, and disease management program development. His work integrates multisite randomized controlled trials, large cohort studies, and complex statistical analysis to develop practical clinical tools including validated risk scores for heart failure readmission. His research bridges environmental factors like air pollution with cardiovascular outcomes and explores the intersection of cancer survivorship with long-term heart failure risk.
Analysis of Dr. Huynh's recent publications reveals a consistent focus on heart failure management optimization, with growing emphasis on cognitive impairment, Long COVID cardiovascular effects, and frailty assessment as determinants of outcomes. His work demonstrates strong methodological diversity spanning clinical trials, systematic reviews, and large epidemiological studies with increasing attention to specialized populations including cancer survivors and cognitively impaired patients.
Dr. Huynh has received numerous scientific awards including:
- Emerging Health Researcher of the Year 2018 Award (BUPA Health Foundation)
- Ralph Reader Prize for best clinical research (Cardiac Society of Australia and New Zealand)
- Ten of The Best Award, clinical science category (Menzies Institute for Medical Research, 2017)
- Young Investigator Award from the European Society of Cardiology (2015)
As a research leader, Dr. Huynh has secured over $6 million in project grants as chief investigator (including 3 as principal investigator), currently leading an NHMRC-funded RCT testing a disease management program for high-risk heart failure patients with cognitive impairment. His group at the Baker Institute focuses on translating research findings into clinical practice, having previously developed a heart failure risk score and disease management program that reduced readmissions. Dr. Huynh actively participates in national collaborations and contributes to expert panels, reflecting his standing in the Australian cardiovascular research community.
